Background And Purpose: The storage of intracavitary electrograms by the automatic implantable defibrillators is one of the latest advantages. The objective of this study was to determine the clinical utility and limitations of electrograms stored by the new generation of defibrillators.
Material And Methods: We have implanted at our institution 43 generators with the facility of storing electrograms; 8 Ventak P2, 17 PRxII, and 1 PRxIII from CPI, 14 Jewel, from Medtronic and 3 Guardian ATP 4215, from Telectronics. All were implanted with an endocavitary system lead, an only one patient needed a subcutaneous patch. Mean age was 57 +/- 16 years, 36 were males and 7 women. The mean left ventricular ejection fraction was 44 +/- 23%. The mean follow up was 6 +/- 8 months (limits 1-20 months).
Results: We registered and analyzed a total of 268 episodes in 20 patients. Fourteen (82%) received what was considered appropriate therapy. Three patients (from 17 with any treatment delivered by the defibrillator) presented an inappropriate therapy. The parameters, "onset" and "stability", were differentiated in each arrhythmia, the "onset" is useful to differentiate sinus tachycardia, but not atrial fibrillation, from ventricular tachycardia. Programming a stability value between 30-40 mseg eliminates 88% of inappropriate therapies due to atrial fibrillation. In all patients, the identification of the event, facilitated by the stored electrograms, allowed us to resolve the problem.
Conclusions: The programmable features "onset" and "stability" allowed us to eliminate a significant number of inappropriate therapies. The stored electrograms facilitate the identification of the events, leading to treatment by the generator, and were very useful in guiding the clinical management of the patient.
Download full-text PDF |
Source |
---|
J Interv Card Electrophysiol
August 2024
Clinic for Interventional Electrophysiology, Heart Centre Bad Neustadt, Von-Guttenberg-Straße 11, 97616, Bad Neustadt an Der Saale, Germany.
Indian Pacing Electrophysiol J
August 2024
Dept of Cardiology, BM Birla Herat Institute, Kolkata, India.
A 50-year-old gentleman with old anterior wall myocardial infarction with implantable cardioverter defibrillator (ICD, Abbott Medical, Fortify ST VR 1235-40) presented with recurrent appropriate ICD shock. The ICD stored EGM indicated a possibility of supraventricular tachycardia (SVT) rather than ventricular tachycardia (VT) when the morphology match was found high. Bundle brunch re-entry (BBR) VT was another differential.
View Article and Find Full Text PDFHeart Rhythm
November 2024
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
Background: Despite effectiveness of the implantable cardioverter-defibrillator (ICD) in saving patients with life-threatening ventricular arrhythmias (VAs), the temporal occurrence of VA after ICD implantation is unpredictable.
Objective: The study aimed to apply machine learning (ML) to intracardiac electrograms (IEGMs) recorded by ICDs as a unique biomarker for predicting impending VAs.
Methods: The study included 13,516 patients who received Biotronik ICDs and enrolled in the CERTITUDE registry between January 1, 2010, and December 31, 2020.
Indian Heart J
May 2024
Department of Cardiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Background: Implantable cardioverter defibrillators (ICD) are often used as primary prevention strategy for sudden cardiac death (SCD) in young individuals. This study analyzed appropriate therapies, complications and inappropriate shocks in the real-world Indian population.
Methods: All patients in the cardiomyopathy cohort under follow up who had ICD implanted as a primary prevention strategy were studied.
J Cardiovasc Electrophysiol
September 2023
Kansas City Heart Rhythm Institute, Overland Park, Kansas, USA.
Introduction: Insertable cardiac monitors (ICMs) are commonly used to diagnose cardiac arrhythmias. False detections in the latest ICM systems remain an issue, primarily due to inaccurate R-wave sensing. New discrimination algorithms were developed and tested to reduce false detections of atrial fibrillation (AF), pause, and tachycardia episodes in ICMs.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!